IC
ELV icon

Inkwell Capital’s Elevance Health ELV Stock Holding History

Inkwell Capital’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.26M Buy
3,265
+23
+0.7% +$8.53K 1.31% 30
2026
Q1 		$949K Sell
3,242
-23
-0.7% -$7.56K 0.97% 29
2025
Q4 		$1.14M Sell
3,265
-14
-0.4% -$4.73K 1.16% 28
2025
Q3 		$1.06M Sell
3,279
-57
-2% -$17.7K 1.08% 28
2025
Q2 		$1.3M Sell
3,336
-40
-1% -$16.1K 1.39% 25
2025
Q1 		$1.47M Buy
3,376
+136
+4% +$54.6K 1.6% 26
2024
Q4 		$1.2M Buy
+3,240
New +$1.36M 1.28% 25

Other funds holding ELV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Inkwell Capital's ELV Position: Q2 2026 in Review

Inkwell Capital increased its Elevance Health (ELV) stake by 0.71% in Q2 2026, buying an estimated $8.53K and bringing the position to 3,265 shares worth $1.26M. The position accounts for 1.31% of the portfolio, ranked #30.

Inkwell Capital first reported a position in ELV in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.47M in Q1 2025. 1,609 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Inkwell Capital held 3,265 shares of Elevance Health worth $1.26M as of Q2 2026.
  • Inkwell Capital bought 23 Elevance Health shares in Q2 2026, an estimated $8.53K.
  • Elevance Health made up 1.31% of Inkwell Capital's portfolio in Q2 2026, its #30 holding.
  • Inkwell Capital first reported a position in Elevance Health in Q4 2024 and has held it in 7 quarters since.
  • Inkwell Capital's Elevance Health position peaked at $1.47M in Q1 2025.
  • 1,609 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Inkwell Capital's 13F filing for Q2 2026, filed 3 Aug 2026.